Company: HCTI
Filing Date: 2025-11-28
Form Type: S-3
Source: 0001213900-25-115888
Chunk: 24

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-28
Form: S-3
Chunk 24
---
 as a result of certain factors, including the risks described in the documents incorporated herein by reference, together with the other information set forth in this prospectus, the risks described in Part I, Item 1A, Risk Factors in our most recent Annual Report on Form 10-K and in the other documents that we include or incorporate by reference into this prospectus, as updated by our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings we make with the SEC, the risk factors described under the caption “Risk Factors” in any applicable prospectus supplement and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, before making a decision about investing in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. If any risks actually occur, our business, financial condition and results of operations may be materially and adversely affected. In such an event, the trading price of our common stock could decline and you could lose part or all of your investment.

Risks Related to the Resale of the Conversion Shares and Ownership of Shares of Our Common Stock

The Selling Stockholders may choose to sell the Conversion Shares at prices below the current market price.

The Selling Stockholders are not restricted as
to the prices at which they may sell or otherwise dispose of the Shares covered by this prospectus. Sales or other dispositions of the
Shares below the then-current market prices could adversely affect the market price of our Common Stock.

A large number of shares of Common Stock may be sold in the market following this offering, which may significantly depress the market price of our Common Stock.

The Conversion Shares sold in the offering will
be freely tradable without restriction or further registration under the Securities Act. As a result, a substantial number of shares of
Common Stock may be sold in the public market following this offering. If there are significantly more shares of Common Stock offered
for sale than buyers are willing to purchase, then the market price of our Common Stock may decline to a market price at which buyers
are willing to purchase the offered Common Stock and sellers remain willing to sell Common Stock.

<div align='center'>12</div>

You may experience future dilution as a result of issuance of the Conversion Shares, future equity offerings by us and other issuances of our Common Stock